Literature DB >> 6681768

Low- and high-risk malignant melanoma--I. Evaluation of clinical and histological prognosticators in 585 cases.

C Schmoeckel, A Bockelbrink, H Bockelbrink, J Koutsis, O Braun-Falco.   

Abstract

In 585 cases with primary cutaneous stage I malignant melanoma (294 disease-free for at least 5 yr, 291 with later metastases) prognostic parameters were examined. The most effective proved to be tumor thickness and mitotic activity, particularly when combined as a prognostic index. Furthermore, vascular invasion, ulceration in thick tumors (thickness greater than or equal to 3.0 mm), severe cellular atypia, the small, lymphocytic-like cell type and the absence of an inflammatory reaction were closely associated with a high rate of metastatic cases. Less relevant prognostic factors were the level of invasion, sex, site, tumor breadth, clinical diameters and infiltrative growth. Tumor type, age, duration and an adjacent nevocellular nevus were not significantly associated with the occurrence of later metastases. Furthermore, the growth-type (exo- or endophytic) did not have a bearing on the prognosis.

Entities:  

Mesh:

Year:  1983        PMID: 6681768     DOI: 10.1016/0277-5379(83)90421-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  8 in total

1.  Professor Dr. Dr. h. c. Otto Braun-Falco.

Authors: 
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.

Authors:  H Ostmeier; J Schumann; F Otto; V Krieg; B Fuchs; B Biess; G Burg; L Suter
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.

Authors:  S M Kheir; S D Bines; J H Vonroenn; S J Soong; M M Urist; J S Coon
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

Review 4.  Management of the regional lymph nodes in patients with cutaneous malignant melanoma.

Authors:  A J Cochran; D R Wen; D L Morton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

Authors:  J W Kelly; R W Sagebiel; S Clyman; M S Blois
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

6.  Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.

Authors:  C Kuehnl-Petzoldt; H Keil; E Schoepf
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

8.  "Mitogenicity"-the latest and mosthilarious episode in the slapstick comedy of melanoma management.

Authors:  Wolfgang Weyers
Journal:  Dermatol Pract Concept       Date:  2012-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.